Figure 7.
DPSC-CM treatment beginning at symptom onset significantly increased post-onset survival and overall lifespan of mSOD1G93A mice. Daily DPSC-CM treatment from symptom onset until end-stage (point of humane euthanasia) significantly increased (A) post-onset survival and (B) extended overall lifespan in mSOD1G93A mice by ~10 days compared to vehicle treatment. *, p < 0.05. (n = 8–9).
